Search Constraints
Search Results
Select an image to start the slideshow
Evaluating the Role of Curli and Gut Escherichia coli Enrichment on Alzheimer’s Disease Outcomes in the 5xFAD Mouse Model
1 of 21
The Impacts of Gut Bacteroides thetaiotaomicron Exposure on Cognitive Impairment and Aβ Pathology in the 5xFAD Alzheimer’s disease Mouse Model
2 of 21
Locus coeruleus physiology in physiology in Alzheimer’s disease
3 of 21
Noradrenergic dysfunction in neurodegenerative disease
4 of 21
Salivary Lactoferrin as a Robust Biomarker of Alzheimer’s Disease
5 of 21
Ten-Eleven Translocation Proteins-Mediated Epigenetic Regulation in Alzheimer’s Disease
6 of 21
Neural codes underlying memory and flexible navigation in health and Alzheimer’s disease
7 of 21
High-fat Diet-induced Diabetes Couples to Alzheimer’s Disease through Inflammation-activated C/EBPb/AEP Pathway
8 of 21
Alzheimer's Disease Pathology Imputation and Risk Prediction Using Clinical Indices
9 of 21
An Investigation of the Role of the Histone Demethylase LSD1, and Its Disordered Domain, in Neuronal Maintenance and Tau-Mediated Neurodegeneration
10 of 21
Molecular Biomarkers in a Cohort of Middle-Aged African Americans and Caucasians with a Family History of Alzheimer’s Disease
11 of 21
Cellular Trafficking and molecular heterogeneity of amyloid beta seeds. How similar are beta amyloid aggregates and prions?
12 of 21
Peripheral immune traffic to the AD brain: role of soluble TNF
signaling and peripheral inflammation
13 of 21
Effect of M1 Muscarinic Receptor Activators on Locomotion in Rats
14 of 21
Next Generation Proteomics in the Nervous System
15 of 21
Investigating the Effects of Specific Acetylcholine Receptor
Activation on Hippocampal Function for the Treatment of Alzheimer's
Disease
16 of 21
Diet may be a Modifiable Risk Factor for Cognitive Decline in African Americans and Caucasians at High Risk for Developing Alzheimer's Disease: A Pilot Study of the Southern and Prudent Diets.
17 of 21
Time-dependent determination of inflammatory mediators in a 5xFADmouse model of Alzheimer's disease
18 of 21
Evidence that pathological Tau functions through inhibition of lysine-specific demethylase 1A in tauopathy model mice
19 of 21
Comprehensive Proteome and Transcriptome Studies Reveal RNA
Processing Dysfunction in Alzheimer's disease
20 of 21
Characterization of naturally occurring, pathogenic and benignAβ multimers Why don't monkeys get Alzheimer'sdisease?
21 of 21